Since then, discussion has faded somewhat, due in part to the relentless messaging from President Trump and others about the coming vaccines. But as the leading western vaccine projects prepare to apply for emergency use from the FDA as soon as November or December, the World Economic Forum, the same supranational organization that organizes the annual forum in Davos, is taking the lead in testing a global standard to communicate that an individual hasn’t been infected with COVID-19.
The project to develop an international standard to communicate whether travelers have been infected with COVID-19 called the CommonPass system is being led by Paul Meyer, the CEO of the Commons Project, a Swiss non-profit financed by the Rockefeller Foundation. Meyer insists countries are looking for better ways to “thoughtfully reopen” their borders as European countries start cutting down intra-EU travel once again.
Right now, travelers’ COVID-19 test results are frequently printed out, with the results often obtained from unknown or uncertified labs.
With CommonPass, travelers would take a test at a certified lab, then the results would be uploaded to their phone. Then they would complete any other health-related questionnaires required by the country to which they’re traveling. Before boarding, airlines can use CP to check whether travelers have met the entry requirements. This can be done by simply scanning a QR code generated by the app.
Even after the COVID-19 pandemic ends, these ‘health passports’ could be used to offer evidence that a traveler has been vaccinated – not just for COVID-19, but for any other diseases.
And even once vaccines are widely available, the world will need a system for patients to prove that they have received the vaccine. Some countries might only allow travelers to enter if they have received a specific vaccine.
“It’s hard to do that,” he told the Guardian. “It requires being able to assess the health of incoming travellers…Hopefully, we’ll soon start to see some vaccines come on to the market, but there is not going to be just one vaccine.”
“Some countries are going to probably say, ‘OK, I want to see documentation you’ve gotten one of these vaccines, but not one of those vaccines.'”
Using data from three medical practices in the United States with children born between November 2005 and June 2015, vaccinated children were compared to unvaccinated children during the first year of life for later incidence of developmental delays, asthma, ear infections and gastrointestinal disorders. All diagnoses utilized International Classification of Diseases–9 and International Classification of Diseases–10 codes through medical chart review. Subjects were a minimum of 3 years of age, stratified based on medical practice, year of birth and gender and compared using a logistic regression model.
Their results showed that the vaccinated group were more than twice as likely to suffer from developmental delays, four times as likely to have asthma, and twice as likely to experience ear infections.
The worse health outcomes appear to be dose-dependent with the higher odds ratios being observed the more vaccine doses received. In their conclusion, the scientists urge more study.
In this study, which only allowed for the calculation of unadjusted observational associations, higher ORs were observed within the vaccinated versus unvaccinated group for developmental delays, asthma and ear infections. Further study is necessary to understand the full spectrum of health effects associated with childhood vaccination.
This adds to a previous pilot study of vaccinated versus unvaccinated homeschoolers, and the research from the pediatric practise of Dr. Paul Thomas who found much higher rates of autism in his practice for those children following the CDC vaccination schedule, versus those who were not.
Safe and Effective™ is the mantra we’re all familiar with. When we’re told a medical product is effective there is an automatic assumption that it has been scientifically proven to treat or prevent what it was designed for. It’s this assumption that proponents of vaccination prey on, hoping the average person will simply take them at their word.
This excerpt from the FLULAVAL monograph (insert) highlights what is a little known fact of the industry – vaccines are never proven to be effective at actually preventing any disease. Rather, they’re said to be effective if they can elicit a temporal antibody response which theoretically might offer some temporary protection.
The problem with the theory is that antibodies do not equal immunity. Some people with high antibody levels still get sick, while others with low antibodies do not. It’s at best, an incomplete theory of immunity that was developed a century ago. Seemingly every decade new breakthroughs occur in our understanding of the immune system and how it works with the crucial role of the gut biome only recently starting to be understood and factored into the equation of how immunity works.
The lack of actual effectiveness is evidenced by the fact that outbreaks in fully vaccinated populations occur regularly. The Pertussis Surveillance Report issued by the CDC in 2017 found 44% of the more than 4,000 cases occurred in people who had received all three vaccinations. This is far from an isolated event, as vaccine failures have occurred regularly over the decades and continue to this day.
Vaccinations are not “effective” in the way the word implies, and are never proven to reduce the incidence of disease only to elicit an antibody response. When weighing the risks versus benefits of a medical intervention that has little if any demonstrable benefits, the allowance for risks should be minimal.